164 related articles for article (PubMed ID: 31296420)
1. Adherence to guideline recommendations for lymph node dissection in squamous cell carcinoma of the penis: Effect on survival and complication rates.
Mistretta FA; Mazzone E; Palumbo C; Knipper S; Tian Z; Nazzani S; Tilki D; Musi G; Perrotte P; Montanari E; Shariat SF; Saad F; Briganti A; de Cobelli O; Karakiewicz PI
Urol Oncol; 2019 Sep; 37(9):578.e11-578.e19. PubMed ID: 31296420
[TBL] [Abstract][Full Text] [Related]
2. The role of inguinal lymph node dissection in men with urethral squamous cell carcinoma.
Werntz RP; Riedinger CB; Fantus RJ; Smith ZL; Packiam VT; Adamsky MA; Smith N; Steinberg GD
Urol Oncol; 2018 Dec; 36(12):526.e1-526.e6. PubMed ID: 30446445
[TBL] [Abstract][Full Text] [Related]
3. Effect of inguinal lymph node dissection in lymph node negative patients with squamous cell carcinoma of the penis.
Tappero S; Piccinelli M; Barletta F; Panunzio A; Cano Garcia C; Incesu RB; Tian Z; Parodi S; Dell'Oglio P; De Cobelli O; Briganti A; Antonelli A; Chun FKH; Graefen M; Saad F; Shariat SF; Suardi NR; Borghesi M; Terrone C; Karakiewicz PI
World J Urol; 2023 Jan; 41(1):119-125. PubMed ID: 36239810
[TBL] [Abstract][Full Text] [Related]
4. A contemporary population-based assessment of the rate of lymph node dissection for penile carcinoma.
Thuret R; Sun M; Lughezzani G; Budaus L; Liberman D; Abdollah F; Morgan M; Johal R; Jeldres C; Latour M; Shariat SF; Iborra F; Guiter J; Patard JJ; Perrotte P; Karakiewicz PI
Ann Surg Oncol; 2011 Feb; 18(2):439-46. PubMed ID: 20839061
[TBL] [Abstract][Full Text] [Related]
5. Management of the lymph nodes in penile cancer.
Heyns CF; Fleshner N; Sangar V; Schlenker B; Yuvaraja TB; van Poppel H
Urology; 2010 Aug; 76(2 Suppl 1):S43-57. PubMed ID: 20691885
[TBL] [Abstract][Full Text] [Related]
6. Clinical Outcomes in Clinical N0 Squamous Cell Carcinoma of the Penis According to Nodal Management: Early, Delayed or Selective (following Dynamic Sentinel Node Biopsy) Inguinal Lymph-Node Dissection.
Nazzani S; Catanzaro M; Biasoni D; Maccauro M; Zaborra C; Stagni S; Torelli T; Macchi A; Tesone A; Lorenzoni A; Piva L; Lanocita R; Colecchia M; Montanari E; Salvioni R; Pizzocaro G; Nicolai N
J Urol; 2021 Aug; 206(2):354-363. PubMed ID: 33843260
[TBL] [Abstract][Full Text] [Related]
7. Patterns of Recurrence following Inguinal Lymph Node Dissection for Penile Cancer: Optimizing Surveillance Strategies.
Chakiryan NH; Dahmen A; Bandini M; Pederzoli F; Marandino L; Albersen M; Roussel E; Zhu Y; Ye DW; Ornellas AA; Catanzaro M; Hakenberg OW; Heidenreich A; Haidl F; Watkin N; Ager M; Chahoud J; Briganti A; Salvioni R; Montorsi F; Necchi A; Spiess PE
J Urol; 2021 Oct; 206(4):960-969. PubMed ID: 34032492
[TBL] [Abstract][Full Text] [Related]
8. Bilateral inguinal lymph-node dissection vs. unilateral inguinal lymph-node dissection and dynamic sentinel node biopsy in clinical N1 squamous cell carcinoma of the penis.
Nazzani S; Catanzaro M; Biasoni D; Maccauro M; Stagni S; Torelli T; Macchi A; Bernasconi V; Taverna A; Sessa D; Lorenzoni A; Piva L; Lanocita R; Cascella T; Cattaneo L; Montanari E; Salvioni R; Nicolai N
Urol Oncol; 2023 Apr; 41(4):210.e1-210.e8. PubMed ID: 36868883
[TBL] [Abstract][Full Text] [Related]
9. Adherence to Guideline Recommendations for Perioperative Chemotherapy in Patients with pN2-3 M0 Squamous Cell Carcinoma of the Penis: Temporal Trends and Survival Outcomes.
Mistretta FA; Cyr SJ; Palumbo C; Mazzone E; Knipper S; Tian Z; Nazzani S; Montanari E; Tilki D; Briganti A; Shariat SF; Perrotte P; Saad F; de Cobelli O; Karakiewicz PI
Clin Oncol (R Coll Radiol); 2020 Apr; 32(4):e93-e101. PubMed ID: 31706712
[TBL] [Abstract][Full Text] [Related]
10. Differences in Survival Associated with Performance of Lymph Node Dissection in Patients with Invasive Penile Cancer: Results from the National Cancer Database.
Correa AF; Handorf E; Joshi SS; Geynisman DM; Kutikov A; Chen DY; Uzzo RG; Viterbo R; Greenberg RE; Smaldone MC
J Urol; 2018 May; 199(5):1238-1244. PubMed ID: 29248557
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Penile Squamous Cell Carcinoma Patients Undergoing Inguinal Lymph Node Dissection.
Azizi M; Peyton CC; Boulware DC; Chipollini J; Juwono T; Pow-Sang JM; Spiess PE
Eur Urol Focus; 2019 Nov; 5(6):1085-1090. PubMed ID: 29937330
[TBL] [Abstract][Full Text] [Related]
12. More lymph node dissection improves survival in patients with newly diagnosed lymph node-positive penile cancer.
Mao W; Huang X; Kong M; Fan J; Geng J
Int Urol Nephrol; 2019 Apr; 51(4):641-654. PubMed ID: 30758771
[TBL] [Abstract][Full Text] [Related]
13. Conditional survival of patients with stage I-III squamous cell carcinoma of the penis: temporal changes in cancer-specific mortality.
Mistretta FA; Palumbo C; Knipper S; Mazzone E; Pecoraro A; Tian Z; Musi G; Perrotte P; Montanari E; Shariat SF; Saad F; Briganti A; de Cobelli O; Karakiewicz PI
World J Urol; 2020 Mar; 38(3):725-732. PubMed ID: 31297629
[TBL] [Abstract][Full Text] [Related]
14. Competing-risks analysis in patients with T1 squamous cell carcinoma of the penis.
Thuret R; Sun M; Abdollah F; Budaus L; Shariat SF; Iborra F; Guiter J; Patard JJ; Karakiewicz PI
BJU Int; 2013 Apr; 111(4 Pt B):E174-9. PubMed ID: 23057865
[TBL] [Abstract][Full Text] [Related]
15. Development and external validation of a prognostic tool for prediction of cancer-specific mortality after complete loco-regional pathological staging for squamous cell carcinoma of the penis.
Sun M; Djajadiningrat RS; Alnajjar HM; Trinh QD; Graafland NM; Watkin N; Karakiewicz PI; Horenblas S
BJU Int; 2015 Nov; 116(5):734-43. PubMed ID: 24552303
[TBL] [Abstract][Full Text] [Related]
16. Adherence to European Association of Urology and National Comprehensive Cancer Network Guidelines Criteria for Inguinal and Pelvic Lymph Node Dissection in Penile Cancer Patients-A Survey Assessment in German-speaking Countries on Behalf of the European Prospective Penile Cancer Study Group.
Suarez-Ibarrola R; Zengerling F; Haccius M; Lebentrau S; Schmid HP; Bier M; Lenart S; Distler FA; Resch I; Oelschlager M; May M; Bolenz C; Gratzke C; Miernik A; Wakileh GA
Eur Urol Focus; 2021 Jul; 7(4):843-849. PubMed ID: 32089496
[TBL] [Abstract][Full Text] [Related]
17. Lymph node metastasis in intermediate-risk penile squamous cell cancer: a two-centre experience.
Hughes BE; Leijte JA; Kroon BK; Shabbir MA; Swallow TW; Heenan SD; Corbishley CM; van Boven HH; Perry MJ; Watkin NA; Horenblas S
Eur Urol; 2010 Apr; 57(4):688-92. PubMed ID: 19647926
[TBL] [Abstract][Full Text] [Related]
18. Wound Complication Rates after Inguinal Lymph Node Dissection: Contemporary Analysis of the NSQIP Database.
Chua KJ; Balraj V; Patel HV; Srivastava A; Doppalapudi SK; Elsamra SE; Jang TL; Singer EA; Ghodoussipour SB
J Am Coll Surg; 2023 Jan; 236(1):18-25. PubMed ID: 36519902
[TBL] [Abstract][Full Text] [Related]
19. Penile carcinoma (pT1 G2): surveillance or inguinal lymph node dissection?
Naumann CM; Filippow N; Seif C; van der Horst C; Roelver L; Braun PM; Juenemann KP; Portillo FJ
Onkologie; 2005 Mar; 28(3):135-8. PubMed ID: 15772463
[TBL] [Abstract][Full Text] [Related]
20. Risks and Benefits of Adjuvant Radiotherapy After Inguinal Lymphadenectomy in Node-positive Penile Cancer: A Systematic Review by the European Association of Urology Penile Cancer Guidelines Panel.
Robinson R; Marconi L; MacPepple E; Hakenberg OW; Watkin N; Yuan Y; Lam T; MacLennan S; Adewuyi TE; Coscione A; Minhas SS; Compérat EM; Necchi A
Eur Urol; 2018 Jul; 74(1):76-83. PubMed ID: 29703686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]